| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/24/2004 | CN1176672C Face-beautifying ointment and its preparing process |
| 11/24/2004 | CN1176670C Active animal protein liquid and its application |
| 11/24/2004 | CN1176669C Immune regulator of amino acid calcium from turtle shell and its preparation |
| 11/24/2004 | CN1176668C Composite biological active capsule and method for preparing the same |
| 11/24/2004 | CN1176667C Medicine for treating gastrosis and enteropathy and its preparing process |
| 11/24/2004 | CN1176666C Health-care mineral food and its preparing process |
| 11/24/2004 | CN1176591C Health-care fragrant crisp cake |
| 11/23/2004 | US6821953 Methods for treating and preventing damage to mucosal tissue |
| 11/23/2004 | US6821779 In medium lacking added buffer or added protein prior to transplantation; cryopreservation |
| 11/23/2004 | US6821775 Viral vector encoding pigment epithelium-derived factor |
| 11/23/2004 | US6821753 Replication incompetent herpes viruses for use in gene therapy |
| 11/23/2004 | US6821516 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 11/23/2004 | US6821513 Method for enhancing hematopoiesis |
| 11/23/2004 | CA2294158C Natural antitumor or antiviral substances and use of the same |
| 11/23/2004 | CA2231803C Lipid extract having anti-inflammatory activity |
| 11/23/2004 | CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 11/18/2004 | WO2004099422A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 11/18/2004 | WO2004099406A1 Method of purifying modified acarian main allergen |
| 11/18/2004 | WO2004099395A2 A method for the generation of neural progenitor cells |
| 11/18/2004 | WO2004099394A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 11/18/2004 | WO2004099391A1 Red pigment originated from hahella chejuensis, having algalcidal effect |
| 11/18/2004 | WO2004099364A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 11/18/2004 | WO2004098670A1 Method of regenerating tooth germ |
| 11/18/2004 | WO2004098632A1 Skin collagen production promoter |
| 11/18/2004 | WO2004098622A2 Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic-pituitary-adrenal axis over-activity |
| 11/18/2004 | WO2004098621A1 Isolated/cloned human nt2 cell lines expressing serotonin and gaba |
| 11/18/2004 | WO2004098540A1 Material for treating paradental diseases |
| 11/18/2004 | WO2004098499A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 11/18/2004 | WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto |
| 11/18/2004 | WO2004098285A2 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
| 11/18/2004 | WO2004087930A8 Adenovirus replication-competent vectors expressing trail |
| 11/18/2004 | WO2004073613A3 A medicine and food |
| 11/18/2004 | WO2004067697B1 Icos+ suppresser t cells |
| 11/18/2004 | WO2004029198A3 Immune t-cell stimulation |
| 11/18/2004 | WO2004000164A3 Amniotic membrane mediated delivery of bioactive molecules |
| 11/18/2004 | WO2003076591A8 Compositions and methods for generating an immune response |
| 11/18/2004 | WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents |
| 11/18/2004 | US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy |
| 11/18/2004 | US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 11/18/2004 | US20040229825 For therapy of infections with a drug resistant bacterium comprising disinfectant including a flavonoid which can enhance efficacy of a beta -lactam antibiotic |
| 11/18/2004 | US20040229795 For oncological diseases and diseases accompanying neovascularization, immune complex-mediated and autoimmune diseases, viral infections, fibrotic and granulomatous diseases, allergic diseases, degenerative diseases of the nervous system and arteriosclerosis |
| 11/18/2004 | US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 11/18/2004 | US20040229786 Autologous treatment of degenerated disc with cells |
| 11/18/2004 | US20040229353 Genetic engineering; incubation osteogenic cells with animal growth regulator; culturing; screening for bone cell spheroids |
| 11/18/2004 | US20040229352 Stimulating aveolar cell proliferation in respiratory tissues via aveolar progenitor cell transplantation; tissue-targeted therapy and engineering |
| 11/18/2004 | US20040229351 Adult multipotent human progenitor tissues for use in xenogenic tissue transplantation; tissue engineering; immunotherapy |
| 11/18/2004 | US20040229340 Method of culturing bacterium cell belonging to enterococcus genus and method of producing killed bacterium cell belonging to enterococcus genus |
| 11/18/2004 | US20040229338 Using transgenic and attenuated salmonella comprising tumor modulatory proteins and pharmceutical conjugate to treat cell proliferative disorders; targeted tissue therapy |
| 11/18/2004 | US20040229333 Electroprocessed fibrin-based matrices and tissues |
| 11/18/2004 | US20040228926 Administering Perna canaliculus and/or Mytilus edulis mussel component which exhibits cytotoxicity to malignant tumor cells |
| 11/18/2004 | US20040228925 Stimulating anticarcinogenic immune response using injections of high molecular weight autologous urine isolates containing tumor associated antigens |
| 11/18/2004 | US20040228876 Composition and Method for Treating Cancer Using Herpes Virus |
| 11/18/2004 | US20040228847 Progenitor cells and methods of using same |
| 11/18/2004 | US20040228845 Methods of using CD8+/TCR- facilitating cells (FC) for the engraftment of purified hematopoietic stem cells (HSC) |
| 11/18/2004 | US20040228841 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 11/18/2004 | US20040228840 Vector for integration of heterologous sequences into poxviral genomes |
| 11/18/2004 | US20040228829 Plasma detoxification system and methods of use |
| 11/18/2004 | CA2748670A1 Dermal micro organs, methods and apparatuses for producing and using the same |
| 11/18/2004 | CA2748661A1 Dermal micro organs, methods and apparatuses for producing and using the same |
| 11/18/2004 | CA2748659A1 Dermal micro organs, methods and apparatuses for producing and using the same |
| 11/18/2004 | CA2524929A1 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
| 11/18/2004 | CA2524611A1 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 11/18/2004 | CA2524063A1 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 11/18/2004 | CA2519680A1 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 11/17/2004 | EP1477555A2 Method for culturing bacterial cells belonging to the enterococcus genus and method of producing killed bacterial cells belonging to the enterococcus genus |
| 11/17/2004 | EP1477184A2 Neospora vaccine |
| 11/17/2004 | EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions |
| 11/17/2004 | EP1477176A1 Malleable bone composition for filling bone defects |
| 11/17/2004 | EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system |
| 11/17/2004 | EP1476548A2 Process of cell electrofusion |
| 11/17/2004 | EP1476540A1 Methods for producing gama delta t cells |
| 11/17/2004 | EP1476206A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disordes |
| 11/17/2004 | EP1476187A2 Methods of extending corneal graft survival |
| 11/17/2004 | EP1476185A2 Antibodies to cd40 |
| 11/17/2004 | EP1476174A2 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same |
| 11/17/2004 | EP1476173A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 11/17/2004 | EP1476063A1 Stem cell and dental pulp harvesting method and apparatus |
| 11/17/2004 | EP1476020A1 Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof |
| 11/17/2004 | EP1430111A4 Culture system for rapid expansion of human embryonic stem cells |
| 11/17/2004 | EP1289999B1 Antitumoral analogs of et-743 |
| 11/17/2004 | EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 11/17/2004 | EP1252322B1 Herpes virus strains for gene therapy |
| 11/17/2004 | EP1242436B1 Oligosaccharide mixture |
| 11/17/2004 | EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
| 11/17/2004 | EP1093375B1 A fibrin sealant from clotting factors in fish blood |
| 11/17/2004 | EP1064064B1 Removal of contaminants from biological products |
| 11/17/2004 | EP0852502B1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 11/17/2004 | CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy |
| 11/17/2004 | CN1546521A Transfer factor specific for SARS virus and method for preparing same |
| 11/17/2004 | CN1546515A Immune RNA specific for SARS virus and method for preparing same |
| 11/17/2004 | CN1546172A Hyper-immune serum for resisting SARS virus and its preparation |
| 11/17/2004 | CN1546165A Technique for preparing transfer factor - complete filtering method |
| 11/17/2004 | CN1546090A Anticancer Chinese traditional medicine preparation and preparation process and application thereof |
| 11/17/2004 | CN1546078A Preparation of Chinese patent medicine for treating hyperplasia of mammary glands |
| 11/17/2004 | CN1546064A Freeze dried microecologic preparation for preventing and treating gallinaceous white dysentery |
| 11/17/2004 | CN1546063A Encephalic proteolytic products of compound Piracetam and its preparation |
| 11/17/2004 | CN1175890C Mastoproliferation treating medicine |
| 11/17/2004 | CN1175889C Hepatopathy treating pills |
| 11/17/2004 | CN1175887C Chinese traditional medicine for removing intense heat from throat and dysphagia, and preparing process thereof |
| 11/17/2004 | CN1175884C Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof |